M. Kanematsu

Interim Analysis of a Phase 2 Open‐Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor‐Induced Osteomalacia

Yutaka Takahashi, Y. Takeuchi, C. Shin, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Safety and Efficacy of Burosumab in Pediatric Patients With X-Linked Hypophosphatemia: A Phase 3/4 Open-Label Trial

K. Ozono, T. Kubota, Y. Seino, 2022, Journal of the Endocrine Society.

Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis.

A. Uezumi, Hiroshi Yamamoto, K. Tsujikawa, 2008, Experimental cell research.

Self-Administration of Burosumab in Children and Adults with X-Linked Hypophosphataemia in Two Open-Label, Single-Arm Clinical Studies

K. Ozono, Y. Takeuchi, Y. Imanishi, 2023, Advances in Therapy.